U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.7076G>A (p.Arg2359Gln) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003235355.1

Allele description [Variation Report for NM_000540.3(RYR1):c.7076G>A (p.Arg2359Gln)]

NM_000540.3(RYR1):c.7076G>A (p.Arg2359Gln)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.7076G>A (p.Arg2359Gln)
Other names:
NM_000540.2(RYR1):c.7076G>A; p.Arg2359Gln
HGVS:
  • NC_000019.10:g.38499683G>A
  • NG_008866.1:g.70984G>A
  • NM_000540.3:c.7076G>AMANE SELECT
  • NM_001042723.2:c.7076G>A
  • NP_000531.2:p.Arg2359Gln
  • NP_000531.2:p.Arg2359Gln
  • NP_001036188.1:p.Arg2359Gln
  • LRG_766t1:c.7076G>A
  • LRG_766:g.70984G>A
  • LRG_766p1:p.Arg2359Gln
  • NC_000019.9:g.38990323G>A
  • NM_000540.2:c.7076G>A
Protein change:
R2359Q
Links:
dbSNP: rs1387126664
NCBI 1000 Genomes Browser:
rs1387126664
Molecular consequence:
  • NM_000540.3:c.7076G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.7076G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003934634Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(May 11, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.

Klingler W, Heiderich S, Girard T, Gravino E, Heffron JJ, Johannsen S, Jurkat-Rott K, Rüffert H, Schuster F, Snoeck M, Sorrentino V, Tegazzin V, Lehmann-Horn F.

Orphanet J Rare Dis. 2014 Jan 16;9:8. doi: 10.1186/1750-1172-9-8.

PubMed [citation]
PMID:
24433488
PMCID:
PMC3896768

Genetic epidemiology of malignant hyperthermia in the UK.

Miller DM, Daly C, Aboelsaod EM, Gardner L, Hobson SJ, Riasat K, Shepherd S, Robinson RL, Bilmen JG, Gupta PK, Shaw MA, Hopkins PM.

Br J Anaesth. 2018 Oct;121(4):944-952. doi: 10.1016/j.bja.2018.06.028. Epub 2018 Aug 17.

PubMed [citation]
PMID:
30236257
PMCID:
PMC6208294

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003934634.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: RYR1 c.7076G>A (p.Arg2359Gln) results in a conservative amino acid change located in the RIH domain (IPR000699) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.4e-06 in 239250 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.7076G>A has been reported in the literature in individuals affected with Malignant Hyperthermia Susceptibility, however without strong evidence for causality (e.g., Klingler_2014, Miller_2018). These reports do not provide unequivocal conclusions about association of the variant with Malignant Hyperthermia Susceptibility. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24433488, 30236257). Three ClinVar submitters (evaluation after 2014), including the ClinGen Malignant Hyperthermia Susceptibility Variant Curation Expert Panel, have cited the variant with conflicting assessments: two submitters (including the expert panel) classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024